What Is the Importance of Representation in Clinical Trials?

In this insightful episode of For Your Health News, Dr. Friedson, Director of Health Economics in the Milken Institute’s Research Department, joins the podcast to explore why representation and demographic balance in clinical trials are essential to better health outcomes.Dr. Friedson explains how gaps in participation can lead directly to gaps in treatment—when research populations don’t reflect real-world communities, the data guiding care may miss critical differences in response, risk, and effectiveness.The conversation dives into the economic and public health implications of underrepresentation, why diversity in trials strengthens science, and how more inclusive research design can help close persistent health disparities.If you care about equitable access to innovation and evidence-based care that works for everyone, this episode is a must-listen.In This Episode, You’ll Learn:• Why demographic balance in clinical trials improves treatment accuracy • How knowledge gaps in research lead to treatment gaps in care • The economic and policy implications of underrepresentation • What institutions can do to improve diversity in enrollment • Why representation strengthens both science and trustJoin us for this important conversation on advancing equity through better research.For more health news that empowers communities, visit fyh.news